American Journal of Cardiology
Volume 105, Issue 3 , Pages 293-296 , 1 February 2010

Major Adverse Cardiac Events in Patients With Moderate to Severe Renal Insufficiency Treated With First-Generation Drug-Eluting Stents

  • Rishi Sukhija, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • Corresponding Author InformationCorresponding author: Tel: (501) 786-0043; fax: (914) 235-6274
    • ,
  • Wilbert S. Aronow, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Chandrasekar Palaniswamy, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Tarunjit Singh, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Rashmi Sukhija, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Kumar Kalapatapu, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Diwakar Mohan, MD

      Affiliations

    • Department of International Health, Johns Hopkins Bloomberg School of Medicine, Baltimore, Maryland
    • ,
  • Anthony L. Pucillo, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Carmine Sorbera, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Priyanka Kakar, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Melvin B. Weiss, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Purshotam Lal, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York
    • ,
  • Craig E. Monsen, MD

      Affiliations

    • Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York

Received 24 August 2009 ,Revised 20 September 2009 ,Accepted 20 September 2009.

References 

  1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  2. Jungers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant. 1997;12:2597–2602
  3. Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001;38:1398–1407
  4. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769–2775
  5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  7. Le Feuvre C. Angioplasty and stenting in patients with renal disease. Heart. 2000;83:7–8
  8. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with endstage renal failure. Nephrol Dial Transplant. 2000;15:218–223
  9. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–1457
  10. Kuchulakanti PK, Torguson R, Chu WW, Canos DA, Rha SW, Clavijo L, et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2006;97:792–797
  11. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J. 2007;71:1525–1529
  12. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, et al. A randomized comparison of sirolimus-versus paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol. 2008;52:727–733
  13. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663–670

PII: S0002-9149(09)02402-3

doi: 10.1016/j.amjcard.2009.09.031

American Journal of Cardiology
Volume 105, Issue 3 , Pages 293-296 , 1 February 2010

Article Tools

* Image Usage & Resolution